Corey Cudzilo, MD
Pulmonary Disease · Knoxville, TNNPI 1003012022
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,260 of the $4,361 with a category attached, or 74.8%. 22 manufacturers reported payments, led by Olympus Corporation Of The Americas at 26.0% of the total. Reporting peaked in 2019 at $1,784 and has fallen 64.6% since, to $631 in 2025.
Across 103 payments — averaging $42.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus Corporation Of The Americas$1K
- AstraZeneca$982
- Amgen$465
- Pfizer$206
- Johnson & Johnson$182
- AbbVie$182
- plus $1K from 16 others
What the payments were for
- Travel & lodging$1,08125%
- Food & beverage$3,26075%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus Corporation Of The Americas | 12 | $1,133 |
| AstraZeneca(2 entities) | 17 | $982 |
| Amgen | 4 | $465 |
| Pfizer | 12 | $206 |
| Johnson & Johnson | 11 | $182 |
| AbbVie(2 entities) | 9 | $182 |
| CSL Behring | 6 | $169 |
| Boehringer Ingelheim | 8 | $163 |
| Electromed, Inc. | 2 | $160 |
| Abbott | 2 | $146 |
| Regeneron Healthcare Solutions, Inc. | 3 | $144 |
| GSK | 2 | $133 |
| United Therapeutics Corporation | 3 | $72 |
| UCB, Inc. | 2 | $56 |
| Gilead | 2 | $34 |
| Genentech USA, Inc. | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Philips North America LLC | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,361 in reported general payments places this provider in the 55th percentile of 339 pulmonary disease providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Knoxville
- John SwisherKnoxville$234K
- John PrinceKnoxville$117K
- Rajiv DhandKnoxville$96K
- Varun ShahKnoxville$64K
- Benjamin BevillKnoxville$31K
- Shannon ByrdKnoxville$23K
- James PharaohKnoxville$20K
- Isaac BineyKnoxville$16K
- Lisa LancasterNashville$519K
- Krishnendu BhadraChattanooga$494K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.